9.61

0.84% 0.08

Pre-market: 10.05 0.44 +4.58%

Adapthealth Corp (AHCO)

Overview News Price History Option Chain Financials Why AHCO Down? Discussions Forecast

Adapthealth Corp stock is traded at $9.61, with a volume of 1.37M. It is up +0.84% in the last 24 hours and up +7.61% over the past month. AdaptHealth Corp is engaged in providing patient-centered, healthcare-at-home solutions including home medical equipment (HME), medical supplies, and related services. It focuses on providing; sleep therapy equipment, supplies, and related services (including CPAP and bi-PAP services) to individuals suffering from obstructive sleep apnea (OSA), medical devices and supplies to patients for the treatment of diabetes (including continuous glucose monitors (CGM and insulin pumps), home medical equipment to patients discharged from acute care and other facilities, oxygen and related chronic therapy services in the home, and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy and nutritional supply needs.

Previous Close:

$9.53

Open:

$9.57

24h Volume:

1.37M

Relative Volume:

0.95

Market Cap:

$1.30B

Revenue:

$3.26B

Net Income/Loss:

$-214.34M

P/E Ratio:

-5.8242

EPS:

-1.65

Net Cash Flow:

$229.32M

1W Performance:

-10.60%

1M Performance:

+7.61%

6M Performance:

-11.88%

1Y Performance:

-7.24%

1-Day Range:

$9.395

$9.73

1-Week Range:

$9.395

$10.96

52-Week Range:

$8.35

$11.90

Adapthealth Corp Stock (AHCO) Company Profile

Name

Adapthealth Corp

Sector

Healthcare (1169)

Industry

Medical Devices (159)

Phone

610-630-6357

Address

220 WEST GERMANTOWN PIKE, PLYMOUTH MEETING, PA

Employee

10,500

Twitter

Next Earnings Date

2024-12-05

Latest SEC Filings

AHCO's Discussions on Twitter

Compare AHCO with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
AHCO Adapthealth Corp	9.61	1.30B	3.26B	-214.34M	229.32M	-1.65
ABT Abbott Laboratories	129.89	225.27B	41.95B	13.40B	6.35B	7.65
BSX Boston Scientific Corp	95.37	140.74B	16.75B	1.85B	2.37B	1.25
SYK Stryker Corp	363.66	138.77B	22.60B	2.99B	3.49B	7.76
MDT Medtronic Plc	92.33	118.39B	33.20B	4.26B	5.47B	3.29
EW Edwards Lifesciences Corp	67.95	39.95B	5.72B	4.17B	259.90M	6.97

Adapthealth Corp Stock (AHCO) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jan-08-24	Downgrade	Jefferies	Buy → Hold
Nov-08-23	Downgrade	BofA Securities	Neutral → Underperform
May-10-23	Downgrade	Deutsche Bank	Buy → Hold
May-10-23	Downgrade	Stifel	Buy → Hold
May-09-23	Downgrade	BofA Securities	Buy → Neutral
Sep-27-21	Initiated	SVB Leerink	Outperform
Jul-14-21	Upgrade	Robert W. Baird	Neutral → Outperform
Apr-13-21	Downgrade	Robert W. Baird	Outperform → Neutral
Mar-18-21	Initiated	Truist	Buy
Jan-26-21	Initiated	BofA Securities	Buy
Dec-10-20	Initiated	UBS	Buy
Aug-10-20	Initiated	Canaccord Genuity	Buy
Jul-01-20	Resumed	SVB Leerink	Outperform
Jun-09-20	Initiated	RBC Capital Mkts	Outperform
Jan-31-20	Initiated	Stifel	Buy
Jan-07-20	Initiated	Jefferies	Buy
Dec-11-19	Initiated	SVB Leerink	Outperform
Dec-10-19	Initiated	Deutsche Bank	Buy

View All

Adapthealth Corp Stock (AHCO) Latest News

Mar 13, 2025

Proficio Capital Partners LLC Makes New Investment in AdaptHealth Corp. (NASDAQ:AHCO) - Defense World

Mar 13, 2025

Mar 12, 2025

Adapthealth at Barclays Conference: Strategic Shifts and Modest Growth - Investing.com India

Mar 12, 2025

Adapthealth at Barclays Conference: Strategic Shifts and Modest Growth By Investing.com - Investing.com UK

Mar 12, 2025

Senior Health, Home Health & Hospice Stocks Q4 Teardown: AdaptHealth (NASDAQ:AHCO) Vs The Rest - Yahoo Finance

Mar 12, 2025

Mar 11, 2025

Adapthealth at Leerink’s Global Healthcare Conference: Strategic Insights - Investing.com

Mar 11, 2025

Adapthealth at Leerink’s Global Healthcare Conference: Strategic Insights By Investing.com - Investing.com UK

Mar 11, 2025

AdaptHealth Corp. to Present at Barclays Global Healthcare Conference - MSN

Mar 11, 2025

Mar 06, 2025

AdaptHealth Corp. to Participate in Upcoming Investor Conferences - WICZ

Mar 06, 2025